Slow Fe (Ferrous Sulfate Extended-Release) Supplementation Guidelines
Slow Fe, an extended-release ferrous sulfate formulation, should be taken as 1-2 tablets daily (50-100 mg elemental iron) on an empty stomach when possible, continued for 2-3 months after hemoglobin normalization to replenish iron stores, with hemoglobin monitoring every 4 weeks until normal range is achieved. 1
Optimal Administration
Take on an empty stomach for best absorption, though taking with food is acceptable if gastrointestinal side effects occur 1. The extended-release formulation (Slow Fe) demonstrates superior absorption compared to rapidly-disintegrating tablets, with 1.3-1.4 times higher iron absorption across all patient populations 2.
Critical Administration Rules:
- Never crush or chew tablets - this causes tooth staining, mouth irritation, and disrupts the extended-release mechanism 1
- Separate from antibiotics by at least 2 hours to avoid absorption interference 3
- Extended-release preparations show improved tolerability, which promotes better adherence 4
Standard Dosing Protocol
For iron deficiency anemia, administer 50-100 mg elemental iron daily 1. Slow Fe typically contains 50 mg elemental iron per tablet, making 1-2 tablets daily appropriate 5.
Dosing Considerations:
- Preparations with 28-50 mg elemental iron content minimize gastrointestinal side effects while maintaining efficacy 6
- Extended-release formulations allow for effective absorption with reduced side effects compared to higher-dose immediate-release products 4
- Excessive doses beyond 50-100 mg daily increase side effects without proportional benefit 6, 7
Monitoring Requirements
Check hemoglobin approximately every 4 weeks until normal range is achieved 1. An adequate response is defined as hemoglobin increase of at least 10 g/L (1 g/dL) after 2 weeks of daily therapy 1, 5.
Baseline Testing Should Include:
- Hemoglobin and hematocrit
- Mean cellular volume (MCV) and mean cellular hemoglobin (MCH)
- Serum ferritin (target >30 μg/L for adults >15 years)
- C-reactive protein to exclude false-negative ferritin results 6
Follow-up Protocol:
- Repeat basic blood tests at 8-10 weeks to assess treatment success 6
- If hemoglobin fails to increase by 1-2 g/dL in one month, consider non-compliance, malabsorption, continued bleeding, or alternative diagnosis 5
Treatment Duration
Continue oral iron for 2-3 months AFTER hemoglobin normalization to fully replenish iron stores 1, 4. This is a critical step - premature discontinuation before store repletion is a common pitfall 1.
Long-term Management:
- Patients with recurrent low ferritin benefit from intermittent oral supplementation 6
- Monitor iron stores every 6-12 months in high-risk patients 6
- Do NOT continue supplementation if ferritin is normal or elevated - this is potentially harmful 8, 6
When Oral Iron is Appropriate
Oral iron (including Slow Fe) should be first-line treatment for:
- Mild anemia in clinically inactive disease 9
- Patients without previous oral iron intolerance 9
- Hemoglobin >100 g/L 9
- Symptomatic iron deficiency without severe anemia 6
When to Switch to Intravenous Iron
Consider IV iron as first-line instead of oral preparations when:
- Clinically active inflammatory bowel disease 9
- Previous intolerance to oral iron 9
- Hemoglobin <100 g/L 9
- Malabsorption documented 5
- Urgent correction needed 6
- Chronic heart failure with iron deficiency 10
The European Society of Cardiology specifically recommends against oral iron in heart failure patients, as it has not been shown effective in this population 10.
Contraindications and Precautions
Absolute contraindications:
- Hemochromatosis or iron overload disorders 8
- Normal or elevated ferritin levels 8
- Active infection (iron promotes bacterial growth) 8
Common side effects include gastrointestinal discomfort, nausea, constipation, or diarrhea 3. These can be minimized by taking with meals, though this reduces absorption 1, 3.
Special Populations
High-Risk Groups Requiring Screening:
- Adolescents with heavy menstruation 6
- Pregnant women (universal supplementation recommended) 11
- Vegetarians/vegans 6
- High-performance athletes 6
- Patients with eating disorders or underweight 6
Pediatric Dosing:
For children 6-12 years, use ferritin cut-off of 15 μg/L; for adolescents 12-15 years, use 20 μg/L 6.
Safety Warning
Accidental iron overdose is a leading cause of fatal poisoning in children under 6 3. Keep all iron products out of reach of children and call poison control immediately if accidental overdose occurs 3.